Table 2

Patients assessed with TCD and MRI/MRA (n = 132): distribution of patients in each category of cerebral vasculopathy

n
TCD and MRI/MRA performed 132 
Normal TCD and MRA, no stroke, no silent stroke (no cerebral vasculopathy risk) 66 
    Isolated abnormal TCD 17 
    Isolated abnormal MRA 
    Isolated silent stroke 21 
    Abnormal TCD + abnormal MRA 
    Abnormal TCD + silent stroke 
    Abnormal MRA + silent stroke 
    Abnormal TCD + abnormal MRA + silent stroke 
    Abnormal TCD + abnormal MRA + overt stroke 
    Normal TCD + overt stroke 
    Unavailable TCD + abnormal MRA + overt stroke 
Stroke or abnormal TCD or abnormal MRA or silent stroke (cerebral vasculopathy risk) 66 
n
TCD and MRI/MRA performed 132 
Normal TCD and MRA, no stroke, no silent stroke (no cerebral vasculopathy risk) 66 
    Isolated abnormal TCD 17 
    Isolated abnormal MRA 
    Isolated silent stroke 21 
    Abnormal TCD + abnormal MRA 
    Abnormal TCD + silent stroke 
    Abnormal MRA + silent stroke 
    Abnormal TCD + abnormal MRA + silent stroke 
    Abnormal TCD + abnormal MRA + overt stroke 
    Normal TCD + overt stroke 
    Unavailable TCD + abnormal MRA + overt stroke 
Stroke or abnormal TCD or abnormal MRA or silent stroke (cerebral vasculopathy risk) 66 

MRI/MRA indicates magnetic resonance imaging/magnetic resonance angiography; and TCD, transcranial Doppler.

Close Modal

or Create an Account

Close Modal
Close Modal